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Abstract
We report the case of a 56-year-old white man who presented at the Emergency Department for
evaluation of dark-red urine. Rapid development of acute renal failure and haemolytic anaemia initially
elicited the hypothesis of a haemolytic-uremic syndrome. A previous exposure to a gas mixture
containing arsenic and copper was later recognized as the probable aetiology while other differential
diagnoses were excluded. Chelating treatment was promptly initiated before laboratorial
confirmation of arsenic and copper poisoning. Renal and haematological recovery was gradually
observed and the patient survived with no sequelae.
Introduction
Haemolytic anaemia may be secondary to a wide range
of causes either inherited or acquired. The former
include disturbances affecting haemoglobin, the membrane-
cytoskeleton complex and enzyme deficiency states. The latter
include mechanical destruction, drugs, infections, auto-
immune disorders or toxic agents.
Toxic agents are an uncommon cause of haemolysis,
which may develop even in people without metabolic
abnormalities. Many chemicals, due to their oxidative
potential, canlead to haemolysis. Other agentsact through
non oxidative, largely unknown mechanisms, such as
arsine, stibine, copper, and lead [1].
Acute poisoning with heavy metals is a rare cause for
evaluation in the Emergency Department. Its identifi-
cation may prove difficult particularly in unconscious
patients with no obvious history. A low-level exposure
may even be disregarded by the patient himself. This may
challenge the initial approach for a problem which can
result in a lethal outcome.
Case presentation
A 56-year-old white man was referred to our Emergency
Department (ED) for evaluation of dark-red urine.
The patient complained of a general feeling of sickness,
diffuse muscle pain, transient episodes of diaphoresis and
Page 1 of 5
(page number not for citation purposes)chills, with no fever, associated with nausea and bilious
vomiting for the past 24 hours. The appearance of dark-red
coloured urine,resembling blood, motivated his search for
medical care.
He denied abdominal pain or any recent traumatic event.
His past medical history was positive for chronic gastritis.
He had no past of nephrolithiasis or haematological
disorders. He was taking a protein-pump inhibitor and
denied use of any over-the-counter substances. He was an
occasional pipe smoker and had no history of alcohol
abuse or illicit drug consumption. His family history was
unremarkable.
On physical examination, his blood pressure was
132/78 mmHg, with a heart rate of 78 beats per minute, a
tympanic temperature of 36.8ºC, and a respiratory rate of
18 breaths per minute. There were no signs of dehydration.
He had no costovertebral angle tenderness. He had no
chronic liver disease stigmata. Further examination, includ-
ing neurological evaluation, was unremarkable. Initial
laboratory data included: Hb = 13.8 g/dL, MCV = 101.4 fL,
MCHC = 32.3 g/dL, RDW = 79.8 fl, WBC = 18.01 × 10
9/L,
P L T = 2 0 9×1 0
9/L; CRP = 8.5 mg/L, Cr = 1.55 mg/dL,
Urea = 80 mg/dL. Urinalysis revealed proteinuria (3+),
leukocyturia (80 cells/HPF), numerous renal tubular
epithelial cells, no erythrocyturia, and absent nitrites or
urobilinogen. Urinary tract ultrasound excluded signs of
lithiasis or obstruction and revealed bilateral renal paren-
chyma hyperechogenicity and slight perirenal oedema at
the right kidney; bladder wall visualization did not show
suspicious lesions and the prostate was normal.
He was admitted to the Urology Department for a
suspected urinary tract infection. A few hours later his
condition deteriorated. He developed jaundice, fever
(38.6°C), diarrhoea and mental confusion. His blood
panel revealed a normocytic normochromic anaemia with
anysocytosis (Hb = 8.0 g/dL, RDW = 83.2 fl), predomi-
nantly indirect hyperbilirrubinemia (TB = 5.82 mg/dL,
DB = 0.51 mg/dL), high LDH (4415 U/L), elevation of
inflammatory markers (WBC = 20.85 × 10
9/L, CRP =
108 mg/L) and worsening renal dysfunction (Cr = 3.59
mg/dL, Urea = 188 mg/dL) (Table 1).
He was transferred to the Intermediate Care Unit of the
Internal Medicine Department. Additional exams included
an ECG with normal sinus rhythm and normal QTc
interval (416 ms), a normal chest X-ray, a blood smear
with rare schizocytes, negative direct and indirect Coombs
tests and a fractional excretion of sodium of 3.49%.
These data pointed to a haemolytic cause for the rapidly
worsening anaemia (Table 1) and acute renal failure in
this context.
The association of acute renal failure and haemolytic
anaemia elicited the hypothesis of a haemolytic-uremic
syndrome. Considering other causes for a haemolytic
physiopathology which could not be immediately
excluded and the severity of the clinical condition of the
patient, plasmapheresis with fresh frozen plasma was
initiated and RBC transfused as needed.
Clinical history was revisited. The patient owned a factory
of zippers where chemical compounds were frequently
used in plating techniques. At this time the patient recalled
accidental inhalation of a possible toxic gas nearly
32 hours before, while performing a new plating process
wearing no protection. The gas resulted from the mixture
of a so-called “tin’s oxidant” with a metal alloy. This
exposure lasted no longer than 5 minutes and nearly
4 hours later he remembered feeling “sick”. Detailed
Table 1. In-hospital laboratorial course
Day 1 Day 1* Day 2 Day 3 Day 5 Day 6 Day 8 Day 10 Day 18
Hb, g/dL 13.8 11.5 8.0 9.4 8.7 7.9 9.3 9.9 10
WBC × 10
9/L 18.01 18.44 20.85 10.56 8.71 8.64 12.39 11.82 12.74
PLT × 10
9/L 209 167 141 69 89 89 124 250 299
CRP, mg/L 8.5 25.4 108.7 52 40.9 28.8 85.5 104 87.9
AST, U/L 112 121 207 57 34 35
ALT, U/L 33 36 193 156 91 31
gGT, U/L 18 19 27
ALP, U/L 71 62 43
TB, mg/dL 2.06 5.82 6.16 0.94 1.02 0.66 0.63
DB, mg/dL 0.43 0.51 0.48 0.23 0.72 0.15 0.14
LDH, U/L 4115 1430 997 659 549 289
Urea, mg/dL 80 135 188 182 144 112 70 65 59
Cr, mg/dL 1.55 2.56 3.59 4.96 4.43 4.34 3.45 3.86 2.79
Exposure to a gas mixture containing arsenic and copper occurred nearly 32 hours before initial medical evaluation. One session of plasmapheresis was
performed at in-hospital day 2. Penicillamine was administrated from day 4 to 7, followed by dimercaprol during 10 days. Transfusion with 1 pack of red
blood cells was performed at day 2. Haemolytic anaemia, renal dysfunction and hepatotoxicity recovered gradually after chelation therapy.
* Laboratorial results at approximately 12 hours of admission.
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ately requested.
At day 3, nearly 90 hours after the accidental exposure, the
composition of the toxic substance was known. “Tin’s
oxidant”, as the patient named it, included 40-45% of
chlorhydric acid (HCl), 1.2-1.4% of copper sulphate
(CuSO4), and 5-6% of arsenic trioxide (As2O3). Plasma-
pheresis was stopped at this time.
Blood and 24-hour urine samples were sent to the
laboratory for measurement of arsenic and copper levels.
Chelation treatment was initiated with Penicillamin
(1800mg/day per os), before laboratorial confirmation,
in order to address both copper and arsenic intoxication.
Initial therapy with intramuscular Dimercaprol was
postponed due to thrombocytopenia.
The patient completed 3 days of Penicillamin, followed by
the administration of intramuscular Dimercaprol 200 mg
at the following regime: 4-hourly in the first 6 days, then
6-hourly at day 7 and 8, and 12-hourly at day 9 and 10.
Simultaneously, forced alkalinisation was performed, with
fluid therapy as necessary.
Quantitative measurements were available at in-hospital
day 7 and confirmed high levels of arsenic and copper in
urine and blood (Table 2). Further measurements
demonstrated a progressive decline under the expected
chelation reaction (Figure 1). In repeated blood gas
analysis there was no methaemoglobin, a possible
consequence of copper intoxication.
During in-hospital stay, patient’s symptoms gradually
vanished and recovery of haematological, renal and liver
disturbances was observed. He did not present any
neurological or respiratory abnormalities. Syalorrhea and
inflammatory signs at intramuscular injection sites devel-
oped as a consequence of dimercaprol treatment. After
13 days of chelation he was discharged and referred for
follow-up appointments at the Internal Medicine and
Nephrology Outpatient Clinic.
One month later he remained asymptomatic. Physical
examination was unremarkable. Six months later his
haemoglobin level and renal function were normal
(Hb = 14.8 g/dL; MCV = 89.1 fL; MCHC = 34.1 g/dL;
Cr = 1.02 mg/dL, Urea = 46 mg/dL). The patient was
discharged.
Discussion
Arsenic is one the four most hazardous toxicants, along
with cadmium, lead, and mercury. Metal poisoning can
result from exposure to inhaled dusts, fumes or vapours.
Another possible route comes from ingestion of contami-
nated food, drinks or by hand-to-mouth exposure [2-4].
This patient presented with many of the classical clinical
findings attributed to arsenic acute intoxication. Initial
unspecific features of acute gastrointestinal findings may
be underappreciated, particularly if a recent exposure is
not known. Acute toxicity with arsenic manifests within
hours as nausea, vomiting, diarrhea, abdominal pain.
Severe poisoning may result in multi-organic failure,
delirium, seizures, coma, and ultimately death. If the
patient survives, bone marrow suppression, peripheral
neuropathy and skin lesions may develop [2-4].
Haemolytic anemia secondary to acute intoxication with
arsenic is a well-recognized effect [2-4]. Arsenic-related
haemolysis may also be a consequence of chronic
intoxication [5].
The gaseous state is one the most toxic forms of arsenic [6].
Cases of intoxication with arsine gas have been published
mostly as a result of accidental work-related exposures [6-9].
Table 2. Arsenic and copper blood and urine concentration 90 hours after
exposure (available at in-hospital day 7)
Results (µg/L) Normal values
Arsenic
24h urine 445 <100 µg/L
Blood 297 <70 µg/L
Copper
24h urine 137.9 15-60 µg/L
Blood 745 0.7-1.5 µg/L
Figure 1. Plotted concentrations of arsenic and copper in
blood and urine samples under chelation therapy. Chelating
therapy was preceded, three days before, by one session of
plasmapheresis. Penicillamine (Pen) was administrated
between days 4 and 7, followed by dimercaprol from days 8 to
18. Normal values: arsenic (24 h urine) <100 µg/L; arsenic
(blood) <70 µg/L; copper (24 h urine) = 15-60 µg/L; copper
(blood) = 0.7-1.5 µg/L.
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symptoms, persons exposed to hazardous levels may be
u n a w a r eo fi t sp r e s e n c e .I nc o n t r a s tw i t hr e p o r t e dc a s e s
following arsenic poisoning [8,10-17], our patient did not
develop respiratory failure.
Additionally, direct heart toxicity may result in distur-
bances of the electrical conduction system [2-4,15]. One
report described an early manifestation of torsade de pointes
after acute arsenic poisoning [18].
We can only retrospectively speculate about the initial
exposure dosage, which possibly was not high enough to
implicate direct respiratory or cardiac damage.
Treatment should be promptly initiated under high
suspicion of a recent intoxication. Primary treatment in
acute arsenic poisoning involves rapid decontamination
and early initiation of chelation therapy with agents such
as dimercaprol (British Anti-Lewsite, BAL), edentate
(EDTA), succimer (DMSA, dimercaptosuccinic acid)
and penicillamine. No specific antidote is available and
there are no controlled trials regarding different thera-
peutic strategies [2-4].
A recent case report has suggested plasma exchange as an
effective early treatment intervention for acute arsenic
poisoning [19]. In our case, plasmapheresis was per-
formed regarding the hypothesis of a haemolytic-uremic
syndrome, before any toxicodrome was suspected.
However, it may have contributed for the benign clinical
course since chelating treatment was only initiated nearly
100 hours after exposure.
In this case, it is not possible to separate the haemolytic
effect of copper from the arsenic one, since copper
intoxication may also cause haemolysis [20]. Methaemo-
globinemia is a frequent complication of copper poison-
ing which may require additional therapeutic strategies
[20]. Its absence in the presented case points against
a major contribution of this metal in patient’s clinical
course.
Conclusion
We report a rare case of haemolytic anaemia following
arsenic and copper acute intoxication. The unusual nature
of this aetiology and the delayed awareness of a possible
toxic exposure challenged the diagnosis.
Common consequences of arsenic poisoning are haemo-
lysis and renal failure.
Because of the severity of the clinical course, including
multi-organic failure and a high risk of death, therapeutic
strategies should presumptively be initiated without
formal laboratory confirmation. Evidence-based treatment
options are limited. Use of chelating agents, such as
dimercarprol, is recommended. Whether plasma exchange
should be a primary, an alternative or additional treatment
option remains unclear, although its early use may be an
effective treatment.
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